Position history for Capital Research Global Investors's holdings in Inhibrx Biosciences, Inc.
Capital Research Global Investors holds 421,575 shares of INBX (Inhibrx Biosciences, Inc.), worth $33.3M as of 2025-Q4. This is a new position. INBX represents 0.0% of Capital Research Global Investors's portfolio.
Current Value
$33.3M
Current Shares
421,575
Total Value Change
$0
Total Shares Change
0
Other major holders of INBX: VIKING GLOBAL INVESTORS LP, MORGAN STANLEY, HighTower Advisors, LLC, BlackRock, Inc.
New |
| 421,575 |
- |
| $33.3M |
| 0.0% |
| $77.98 |
40 |